• Seeking Alpha

ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.

Seeking Alpha / 31 minutes from now 1 Views

August 28, 2025
News Release

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
A.I.S. Resources Announces Private Placement and Provides Bi-Weekly Default Status Report
Next post
ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics.

Comments

Just Posted

  • Nuvini Group Regains Compliance with Nasdaq Listing Rule 5550(b)(2)

    3 hours from now

  • SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

    3 hours from now

  • Ormat Technologies Announces Strategic Commercial Agreement With Sage Geosystems Inc.

    3 hours from now

  • La-Z-Boy Incorporated Announces Participation In Goldman Sachs 32nd Annual Global Retailing Conference

    3 hours from now

  • SEGG Media backed Veloce Media Group boasts strong quarter with blue-chip partnerships for newly acquired Quadrant

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1781

Categories

  • Seeking Alpha 1781

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts